Bioventus reiterates 2026 guidance after FDA device reclassification
Go back to Bioventus reiterates 2026 guidance after FDA device reclassification| Global Beverage Solutions, Inc. (NASDAQ: BVS) | Delayed: 14.13 +0.15 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.98 | 52 Week High | $0.01 | |||
| Open | $13.99 | 52 Week Low | $0.01 | |||
| Day High | $14.29 | P/E | N/A | |||
| Day Low | $13.72 | EPS | $0.00 | |||
| Volume | 939,733 | |||||
